An association of transferrin gene polymorphism and serum transferrin levels with age-related macular degeneration

Experimental Eye Research

Volumn 106, Issue , 2013, Pages 14-23

  Wysokinski, Daniel ^a   Danisz, Katarzyna ^a   Blasiak, Janusz ^a   Dorecka, Mariola ^b   Romaniuk, Dorota ^b   Szaflik, Jerzy ^c   Szaflik, Jacek Pawel ^c  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

AMD; BMI; Genetic polymorphism; Iron; Oxidative stress; Smoking; Transferrin

Indexed keywords

IRON; TRANSFERRIN;

AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRANSFERRIN BLOOD LEVEL;

AGED; COLORING AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCEIN ANGIOGRAPHY; GENE-ENVIRONMENT INTERACTION; GENOTYPE; HOMEOSTASIS; HUMANS; INDOCYANINE GREEN; IRON COMPOUNDS; MACULAR DEGENERATION; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TOMOGRAPHY, OPTICAL COHERENCE; TRANSFERRIN;

EID: 84870333455     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.10.003     Document Type: Article

References (107)

1. Adrian G.S., Seto E., Fischbach K.S., Rivera E.V., Adrian E.K., Herbert D.C., Walter C.A., Weaker F.J., Bowman B.H. YY1 and Sp1 transcription factors bind the human transferrin gene in age-related manner. J. Gerontol. A Biol. Sci. Med. Sci. 1996, 51:B66-B75.
2. Age-Related Eye Disease Study Research Group Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 2000, 107:2224-2232.
3. Ayala-Haedo J.A., Gallins P.J., Whitehead P.L., Schwartz S.G., Kovach J.L., Postel E.A., Agarwal A., Wang G., Haines J.L., Pericak-Vance M.A., Scott W.K. Analysis of single nucleotide polymorphisms in the NOS2A gene and interaction with smoking in age-related macular degeneration. Ann. Hum. Genet. 2010, 74:195-201.
4. Ayene I.S., Koch C.J., Krisch R.E. DNA strand breakage by bivalent metal ions and ionizing radiation. Int. J. Radiat. Biol. 2007, 83:195-210.
5. Beatty S., Koh H., Phil M., Henson D., Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2000, 45:115-134.
6. Berg D., Youdim M.B. Role of iron in neurodegenerative disorders. Top. Magn. Reson. Imaging 2006, 17:5-17.
7. Beutler E., Gelbart T., Lee P., Trevino R., Fernandez M.A., Fairbanks V.F. Molecular characterization of a case of atransferrinemia. Blood 2000, 96:4071-4074.
8. Bird A.C., Bressler N.M., Bressler S.B., Chisholm I.H., Coscas G., Davis M.D., Jong P.T., Klaver C.C., Klein B.E., Klein R., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv. Ophthalmol. 1995, 39:367-374.
9. Breuer W., Hershko C., Cabantchik Z.I. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus. Sci. 2000, 23:185-192.
10. Brissot P., Ropert M., Le Lan C., Loreal O. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim. Biophys. Acta - Gen. Subj. 2011, 1820:403-410.
11. Bush A.I., Curtain C.C. Twenty years of metallo-neurobiology: where to now?. Eur. Biophys. J. 2008, 37:241-245.
12. Buys S.S., Martin C.B., Eldridge M., Kushner J.P., Kaplan J. Iron absorption in hypotransferrinemic mice. Blood 1991, 78:3288-3290.
13. Cano M., Thimmalappula R., Fujihara M., Nagai N., Sporn M., Wang A.L., Neufeld A.H., Biswal S., Handa J.T. Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and Age-related Macular Degeneration. Vis. Res. 2010, 50:652-664.
14. Cepeda-Lopez A.C., Aeberli I., Zimmermann M.B. Does obesity increase risk for iron deficiency? A review of the literature and the potential mechanisms. Int. J. Vitam. Nutr. Res. 2010, 80:263-270.
15. Chiu C.J., Conley Y.P., Gorin M.B., Gensler G., Lai C.Q., Shang F., Taylor A. Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2011, 52:9099-9107.
16. Chowers I., Wong R., Dentchev T., Farkas R.H., Iacovelli J., Gunatilaka T.L., Medeiros N.E., Presley J.B., Campochiaro P.A., Curcio C.A., Dunaief J.L., Zack D.J. The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2006, 47:2135-2140.
17. Chu J., Zhou C.C., Lu N., Zhang X., Dong F.T. Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population. Chin. Med. J. 2008, 121:2525-2533.
18. Clark S.F. Iron deficiency anemia. Nutr. Clin. Pract. 2008, 23:128-141.
19. Clemons T.E., Milton R.C., Klein R., Seddon J.M., Ferris F.L., Age-Related Eye Disease Study Research Group Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS). AREDS report no. 19. Ophthalmology 2005, 112:533-539.
20. Coleman H., Chew E. Nutritional supplementation in age-related macular degeneration. Curr. Opin. Ophthalmol. 2007, 18:220-223.
21. Coleman H.R., Chan C.C., Ferris F.L., Chew E.Y. Age-related macular degeneration. Lancet 2008, 372:1835-1846.
22. Dargel R. Lipid peroxidation-a common pathogenetic mechanism?. Exp. Toxicol. Pathol. 1992, 44:169-181.
23. De La Paz M.A., Zhang J., Fridovich I. Antioxidant enzymes of the human retina: effect of age on enzyme activity of macula and periphery. Curr. Eye Res. 1996, 15:273-278.
24. Delcourt C., Delyfer M.N., Rougier M.B., Amouyel P., Colin J., Le Goff M., Malet F., Dartigues J.F., Lambert J.C., Korobelnik J.F. Associations of complement factor H and smoking with early age-related macular degeneration: the ALIENOR study. Invest. Ophthalmol. Vis. Sci. 2011, 52:5955-5962.
25. Donovan A., Roy C.N., Andrews N.C. The ins and outs of iron homeostasis. Physiology 2006, 21:115-123.
26. Dunaief J.L., Richa C., Franks E.P., Schultze R.L., Aleman T.S., Schenck J.F., Zimmerman E.A., Brooks D.G. Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload. Ophthalmology 2005, 112:1062-1065.
27. Ellervik C., Tybjaerg-Hansen A., Nordestgaard B.G. Risk of cancer by transferrin saturation levels and haemochromatosis genotype: population-based study and meta-analysis. J. Intern. Med. 2012, 271:51-63.
28. Fine S.L., Berger J.W., Maguire M.G., Ho A.C. Age-related macular degeneration. N. Engl. J. Med. 2000, 342:483-492.
29. Galaris D., Pantopoulos K. Oxidative stress and iron homeostasis: mechanistic and health aspects. Crit. Rev. Clin. Lab. Sci. 2008, 45:1-23.
30. Ganguli A., Kohli H.S., Khullar M., Lal Gupta K., Jha V., Sakhuja V. Lipid peroxidation products formation with various intravenous iron preparations in chronic kidney disease. Ren. Fail. 2009, 31:106-110.
31. Gao X., Qian M., Campian J.L., Marshall J., Zhou Z., Roberts A.M., Kang Y.J., Prabhu S.D., Sun X.F., Eaton J.W. Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload. Free Radic. Biol. Med. 2010, 49:401-407.
32. Garrick M.D., Garrick L.M. Cellular iron transport. Biochim. Biophys. Acta 2009, 1790:309-325.
33. Garrick M.D. Human iron transporters. Genes Nutr. 2011, 6:45-54.
34. Gehrs K.M., Anderson D.H., Johnson L.V., Hageman G.S. Age-related macular degeneration - emerging pathogenetic and therapeutic concepts. Ann. Med. 2006, 38:450-471.
35. Gurzau E.S., Neagu C., Gurzau A.E. Essential metals-case study on iron. Ecotoxicol. Environ. Saf. 2003, 56:190-200.
36. Hahn P., Milam A.H., Dunaief J.L. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Arch. Ophthalmol. 2003, 121:1099-1105.
37. Janssen M.C., Swinkels D.W. Hereditary haemochromatosis. Best Pract. Res. Clin. Gastroenterol. 2009, 23:171-183.
38. 2+. J. Phys. Chem. B 2008, 112:4461-4464.
39. Johnson E.J. Obesity, lutein metabolism, and age-related macular degeneration: a web of connections. Nutr. Rev. 2005, 63:9-15.
40. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283:65-87.
41. Justilien V., Pang J.J., Renganathan K., Zhan X., Crabb J.W., Kim S.R., Sparrow J.R., Hauswirth W.W., Lewin A.S. SOD2 knockdown mouse model of early AMD. Invest. Ophthalmol. Vis. Sci. 2007, 48:4407-4420.
42. Keys S.A., Zimmerman W.F. Antioxidant activity of retinol, glutathione, and taurine in bovine photoreceptor cell membranes. Exp. Eye Res. 1999, 68:693-702.
43. Killilea D.W., Wong S.L., Cahaya H.S., Atamna H., Ames B.N. Iron accumulation during cellular senescence. Ann. N. Y. Acad. Sci. 2004, 1019:365-367.
44. Klein R., Klein B.E.K., Linton K.L.P., DeMets D.L. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am. J. Epidemiol. 1993, 137:190-200.
45. Klein R., Peto T., Bird A., Vannerwkirk M.R. The epidemiology of age-related macular degeneration. Am. J. Ophthalmol. 2004, 137:486-495.
46. Klein R., Klein B.E., Knudtson M.D., et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 2006, 113:373-380.
47. Knudtson M.D., Klein R., Klein B.E. Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Br. J. Ophthalmol. 2006, 90:1461-1463.
48. Kohgo Y., Ikuta K., Ohtake T., Torimoto Y., Kato J. Body iron metabolism and pathophysiology of iron overload. Int. J. Hematol. 2008, 88:7-15.
49. Kolahdooz F., van der Pols J.C., Bain C.J., Marks G.C., Hughes M.C., Whiteman D.C., Webb P.M., Australian Cancer Study (Ovarian Cancer), The Australian Ovarian Cancer Study Group Meat, fish, and ovarian cancer risk: results from 2 Australian case-control studies, a systematic review, and meta-analysis. Am. J. Clin. Nutr. 2010, 91:1752-1763.
50. Kowaltowski A.J., de Souza-Pinto N.C., Castilho R.F., Vercesi A.E. Mitochondria and reactive oxygen species. Free Radic. Biol. Med. 2009, 47:333-343.
51. Lécureuil C., Saleh M.C., Fontaine I., Baron B., Zakin M.M., Guillou F. Transgenic mouse as a model to study the regulation of human transferrin expression in Sertoli cells. Hum. Reprod. 2004, 19:1300-1307.
52. Lee P.H., Shatkay H. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res. 2008, 36:D820-D824.
53. Lee D.H., Liu D.Y., Jacobs D.R., Shin H.R., Song K., Lee I.K., Kim B., Hider R.C. Common presence of non-transferrin-bound iron among patients with type 2 diabetes. Diabetes Care 2006, 29:1090-1095.
54. Lehmann D.J., Schuur M., Warden D.R., Hammond N., Belbin O., Kölsch H., Lehmann M.G., Wilcock G.K., Brown K., Kehoe P.G., Morris C.M., Barker R., Coto E., Alvarez V., Deloukas P., Mateo I., Gwilliam R., Combarros O., Arias-Vásquez A., Aulchenko Y.S., Ikram M.A., Breteler M.M., van Duijn C.M., Oulhaj A., Heun R., Cortina-Borja M., Morgan K., Robson K., Smith A.D. Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project. Neurobiol. Aging 2012, 33:202.e1-202.e13.
55. Liochev S.I., Fridovich I. The Haber-Weiss cycle - 70 years later: an alternative view. Redox Rep. 2002, 7:55-57.
56. Luciani N., Brasse-Lagnel C., Poli M., Anty R., Lesueur C., Cormont M., Laguerriere A., Folope V., LeMarchand-Brustel Y., Gugenheim J., Gual P., Tran A., Bekri S. Hemojuvelin: a new link between obesity and iron homeostasis. Obesity 2011, 19:1545-1551.
57. Luciano M., Houlihan L.M., Harris S.E., Gow A.J., Hayward C., Starr J.M., Deary I.J. Association of the existing and new candidate genes for anxiety, depression and personality traits in older people. Behav. Genet. 2010, 40:518-532.
58. Lukinova N., Iacovelli J., Dentchev T., Wolkow N., Hunter A., Amado D., Ying G.S., Sparrow J.R., Dunaief J.L. Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli. Invest. Ophthalmol. Vis. Sci. 2009, 50:1440-1447.
59. Mares-Perlman J.A., Fisher A.I., Klein R., Palta M., Block G., Millen A.E., Wright J.D. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am. J. Epidemiol. 2001, 153:424-432.
60. Martin P.M., Gnana-Prakasam J.P., Roon P., Smith R.G., Smith S.B., Ganapathy V. Expression and polarized localization of the hemochromatosis gene product HFE in retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2006, 47:4238-4244.
61. McConnell V., Silvestri G. Age-related macular degeneration. Ulst. Med. J. 2005, 74:82-92.
62. Meerang M., Nair J., Sirankapracha P., Thephinlap C., Srichairatanakool S., Arab K., Kalpravidh R., Vadolas J., Fucharoen S., Bartsch H. Accumulation of lipid peroxidation-derived DNA lesions in iron-overloaded thalassemic mouse livers: comparison with levels in the lymphocytes of thalassemia patients. Int. J. Cancer 2009, 125:759-766.
63. Munch I.C., Sander B., Kessel L., Hougaard J.L., Taarnhøj N.C., Sørensen T.I., Kyvik K.O., Larsen M. Heredity of small hard drusen in twins aged 20-46 years. Invest. Ophthalmol. Vis. Sci. 2007, 48:833-838.
64. Muñoz M., Villar I., García-Erce J.A. An update on iron physiology. World J. Gastroenterol. 2009, 15:4617-4626.
65. Murdaugh L.S., Avalle L.B., Mandal S., Dill A.E., Dillon J., Simon J.D., Gaillard E.R. Compositional studies of human RPE lipofuscin. J. Mass. Spectrom. 2010, 45:1139-1147.
66. Nadadur S.S., Srirama K., Mudipalli A. Iron transport & homeostasis mechanisms: their role in health & disease. Indian J. Med. Res. 2008, 128:533-544.
67. Neuner B., Komm A., Wellmann J., Dietzel M., Pauleikhoff D., Walter J., Busch M., Hense H.W. Smoking history and the incidence of age-related macular degeneration-results from the Muenster Aging and Retina Study (MARS) cohort and systematic review and meta-analysis of observational longitudinal studies. Addict. Behav. 2009, 34:938-947.
68. Oliveira B.F., Nogueira-Machado J.A., Chaves M.M. The role of oxidative stress in the aging process. Sci. World J. 2010, 15:1121-1128.
69. Organisciak D.T., Noell W.K. The rod outer segment phospholipid/opsin ratio of rats maintained in darkness or cyclic light. Invest. Ophthalmol. Vis. Sci. 1977, 16:188-190.
70. Organisciak D.T., Bicknell I.R., Darrow R.M. The effects of l- and d-ascorbic acid administration on retinal tissue levels and light damage in rats. Curr. Eye Res. 1992, 11:231-241.
71. Parisi V., Tedeschi M., Gallinaro G., Varano M., Saviano S., Piermarocchi S., CARMIS Study Group Carotenoids and antioxidants in age-related maculopathy Italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology 2008, 115:324-333.
72. Parkkinen J., et al. Function and therapeutic development of apotransferrin. Vox. Sang. 2002, 83:321-326.
73. Peeters A., Magliano D.J., Stevens J., Duncan B.B., Klein R., Wong T.Y. Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. Arch. Ophthalmol. 2008, 126:1554-1560.
74. Picard E., Fontaine I., Jonet L., Guillou F., Behar-Cohen F., Courtois Y., Jeanny J.C. The protective role of transferrin in Müller glial cells after iron-induced toxicity. Mol. Vis. 2008, 20:928-941.
75. Picard E., Jonet L., Sergeant C., Vesvres M.H., Behar-Cohen F., Courtois Y., Jeanny J.C. Overexpressed or intraperitoneally injected human transferrin prevents photoreceptor degeneration in rd10 mice. Mol. Vis. 2010, 8:2612-2625.
76. Qu M., Yue W., Tang F., Wang L., Han Y., Zhang D. Polymorphisms of transferrin gene are associated with schizophrenia in Chinese Han population. J. Psychiatr. Res. 2008, 42:877-883.
77. Roth F., Bindewald A., Holz F.G. Key pathophysiologic pathways in age-related macular disease. Graefes Arch. Clin. Exp. Ophthalmol. 2004, 242:710-716.
78. Salvi S.M., Akhtar S., Currie Z. Ageing changes in the eye. Postgrad. Med. J. 2006, 82:581-587.
79. Santos P.C., Krieger J.E., Pereira A.C. Molecular diagnostic and pathogenesis of hereditary hemochromatosis. Int. J. Mol. Sci. 2012, 13:1497-1511.
80. Santovito A., Cervella P., Schleicherova D., Delpero M. Genotyping for cytokine polymorphisms in a Northern Ivory Coast population reveals a high frequency of the heterozygote genotypes for the TNF-α-308G/A SNP. Int. J. Immunogenet. 2012, 39:291-295.
81. Sawyer D.E., Mercer B.G., Wiklendt A.M., Aitken R.J. Quantitative analysis of gene-specific DNA damage in human spermatozoa. Mutat. Res. 2003, 28:21-34.
82. Sebastiani G., Pantopoulos K. Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice. Metallomics 2011, 3:971-986.
83. Seddon J.M., Ajani U.A., Sperduto R.D., Hiller R., Blair N., Burton T.C., Farber M.D., Gragoudas E.S., Haller J., Miller D.T., et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994, 272:1413-1420.
84. Seddon J.M., Gensler G., Milton R.C., Klein M.L., Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004, 291:704-710.
85. Seddon J.M., George S., Rosner B., Klein M.L. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum. Hered. 2006, 61:157-165.
86. Seddon J.M., Reynolds R., Rosner B. Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration. Mol. Vis. 2010, 17:2412-2424.
87. Sellis D., Callahan B.J., Petrov D.A., Messer P.W. Heterozygote advantage as a natural consequence of adaptation in diploids. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:20666-20671.
88. Shahid H., Khan J.C., Cipriani V., Sepp T., Matharu B.K., Bunce C., Harding S.P., Clayton D.G., Moore A.T., Yates J.R. Age-related macular degeneration: the importance of family history as a risk factor. Br. J. Ophthalmol. 2012, 96:427-431.
89. Shvartsman M., Kikkeri R., Shanzer A., Cabantchik Z.I. Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications. Am. J. Physiol. Cell. Physiol. 2007, 293:1383-1394.
90. Siah C.W., Ombiga J., Adams L.A., Trinder D., Olynyk J.K. Normal iron metabolism and the pathophysiology of iron overload disorders. Clin. Biochem. Rev. 2006, 27:5-16.
91. Sickel W. Retinal metabolism in dark and light. Handbook of Sensory Physiology 1972, 667-727. Springer-Verlag. M.G.F. Fuortes (Ed.).
92. Sliney D.H. How light reaches the eye and its components. Int. J. Toxicol. 2002, 21:501-509.
93. Srivastava S., Chandra A., Bhatnagar A., Srivastava S.K., Ansari N.H. Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase. Biochem. Biophys. Res. Commun. 1995, 217:741-746.
94. Stadtman E.R., Levine R.L. Protein oxidation. Ann. N. Y. Acad. Sci. 2000, 899:191-208.
95. Suñer I.J., Espinosa-Heidmann D.G., Marin-Castano M.E., Hernandez E.P., Pereira-Simon S., Cousins S.W. Nicotine increases size and severity of experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 2004, 45:311-317.
96. 2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 1995, 36:1271-1279.
97. Theil E.C., Goss D.J. Living with iron (and oxygen): questions and answers about iron homeostasis. Chem. Rev. 2009, 109:4568-4579.
98. Thornton J., Edwards R., Mitchell P., Harrison R.A., Buchan I., Kelly S.P. Smoking and age-related macular degeneration: a review of association. Eye (Lond.) 2005, 19:935-944.
99. Umur E.E., Oktenli C., Celik S., Tangi F., Sayan O., Sanisoglu Y.S., Ipcioglu O., Terekeci H.M., Top C., Nalbant S., Kucukardali Y. Increased iron and oxidative stress are separately related to cognitive decline in elderly. Geriatr. Gerontol. Int. 2011, 11:504-509.
100. Walker B.L., Tiong J.W., Jefferies W.A. Iron metabolism in mammalian cells. Int. Rev. Cytol. 2001, 211:241-278.
101. Wang A.L., Lukas T.J., Yuan M., Du N., Handa J.T., Neufeld A.H. Changes in retinal pigment epithelium related to cigarette smoke: possible relevance to smoking as a risk factor for age-related macular degeneration. PLoS One 2009, 4:5304.
102. Yamada Y., Shigetomi H., Onogi A., Haruta S., Kawaguchi R., Yoshida S., Furukawa N., Nagai A., Tanase Y., Tsunemi T., Oi H., Kobayashi H. Redox-active iron-induced oxidative stress in the pathogenesis of clear cell carcinoma of the ovary. Int. J. Gynecol. Cancer 2011, 21:1200-1207.
103. Yefimova M.G., Jeanny J.C., Guillonneau X., Keller N., Nguyen-Legros J., Sergeant C., Guillou F., Courtois Y. Iron, ferritin, transferrin, and transferrin receptor in the adult rat retina. Invest. Ophthalmol. Vis. Sci. 2000, 41:2343-2351.
104. Zafon C., Lecube A., Simó R. Iron in obesity. An ancient micronutrient for a modern disease. Obes. Rev. 2010, 11:322-328.
105. Zakin M.M., Baron B., Guillou F. Regulation of tissue-specific expression of transferrin gene. Dev. Neurosci. 2002, 24:222-226.
106. Zarbin M.A. Current concepts in the pathogenesis of age-related macular degeneration. Arch. Ophthalmol. 2004, 122:598-614.
107. Zecca L., Youdim M.B., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 2004, 5:863-873.